HIPEC with CRS versus cytoreductive surgery (CRS) for the gastric cancer metastasis to peritoneum

被引：4
作者：
Chen, Zhuming [1 ]
Ali, Muhammad [2 ,3 ]
Kai, Zhe [1 ]
Wang, Yang [2 ,3 ]
Wang, Chaohui [1 ]
机构：
[1] Anhui Med Univ, Dept Gen Surg, Anqing Peoples Hosp 1, Hefei, Peoples R China
[2] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Yangzhou 225001, Jiangsu, Peoples R China
[3] Yangzhou Univ, Med Coll, Yangzhou 225001, Jiangsu, Peoples R China
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2023年 / 25卷 / 04期
关键词：
Hyperthermic intraperitoneal chemotherapy; Peritoneal metastasis; Gastrectomy and gastric cancer; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CARCINOMATOSIS;
D O I：
10.1007/s12094-022-03004-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background Peritoneal metastases (PM) have a poor prognosis in gastric cancer (GC). Cytoreductive surgery (CRS) gives favorable outcomes, but the influence of hyperthermic intraperitoneal chemotherapy (HIPEC) remains contentious. We designed to distinguish results between CRS versus HIPEC-CRS in patients with peritoneal metastases from gastric cancer. Materials and methods PubMed, Scopus, Embase and Cochrane library accessed to collect data and language is restricted to English. RevMan 5.4 was used to perform statistical analysis. The outcomes for categorical variables are mentioned in the risk ratio. Results Ten trials involving 1367 patients in which 707 were CRS-HIPEC, while 660 CRS. We got significant results in 3rd year survival (P < 0.05), while 1st and 5th years are not statistically significant P > 0.05. Conclusion To compare with CRS, CRS-HIPEC has improved survival rate in deprived of further morbidity or mortality.
引用
收藏
页码：1011 / 1016
页数：6
相关论文
共 18 条
  • [1] [Anonymous], 2012, G ESTIMATED CANC INC
  • [2] Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
    Beeharry, Maneesh Kumarsing
    Zhu, Zheng-Lun
    Liu, Wen-Tao
    Yao, Xue-Xin
    Yan, Min
    Zhu, Zheng-Gang
    [J]. BMC CANCER, 2019, 19 (01)
  • [3] Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
    Bonnot, Pierre-Emmanuel
    Piessen, Guillaume
    Kepenekian, Vahan
    Decullier, Evelyne
    Pocard, Marc
    Meunier, Bernard
    Bereder, Jean-Marc
    Abboud, Karine
    Marchal, Frederic
    Quenet, Francois
    Goere, Diane
    Msika, Simon
    Arvieux, Catherine
    Pirro, Nicolas
    Wernert, Romuald
    Rat, Patrick
    Gagniere, Johan
    Lefevre, Jeremie H.
    Courvoisier, Thomas
    Kianmanesh, Reza
    Vaudoyer, Delphine
    Rivoire, Michel
    Meeus, Pierre
    Passot, Guillaume
    Glehen, Olivier
    Abba, Julio
    Alyami, Mohammad
    Bakrin, Naoual
    Bernard, Jean-Louis
    Bibeau, F.
    Bouzard, Dominique
    Brigand, C.
    Carrere, Sebastien
    Carretier, Michel
    Castel, Benjamin
    Cotte, Eddy
    Celerier, Bertrand
    Ceribelli, Cecilia
    De Chaisemartin, Cecile
    De Franco, Valeria
    Deguelte-Lardiere, Sophie
    Debre, Robert
    Delpero, Jean-Robert
    Desolneux, Gregoire
    Dumont, Frederic
    Eveno, Clarisse
    Durand-Fontanier, Sylvaine
    Evrard, Serge
    Facy, Olivier
    Gilly, Francois-Noel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (23) : 2028 - +
  • [4] Advanced gastric cancer: what we know and what we still have to learn
    Coccolini, Federico
    Montori, Giulia
    Ceresoli, Marco
    Cima, Simona
    Valli, Maria Carla
    Nita, Gabriela E.
    Heyer, Arianna
    Catena, Fausto
    Ansaloni, Luca
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (03) : 1139 - 1159
  • [5] Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
    Cui, Hai-Bin
    Ge, Huai-E
    Bai, Xi-Yong
    Zhang, Wei
    Zhang, Yuan-Yuan
    Wang, Juan
    Li, Xing
    Xing, Lian-Ping
    Guo, Sheng-Hu
    Wang, Zhi-Yu
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (05) : 1083 - 1088
  • [6] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
    Deraco, Marcello
    Kusamura, Shigeki
    Virzi, Salvatore
    Puccio, Francesco
    Macri, Antonio
    Famulari, Ciro
    Solazzo, Massimiliano
    Bonomi, Serena
    Iusco, Domenico Rosario
    Baratti, Dario
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 215 - 220
  • [7] Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial
    Glockzin, Gabriel
    Zeman, Florian
    Croner, Roland S.
    Koenigsrainer, Alfred
    Pelz, Joerg
    Strohlein, Michael A.
    Rau, Beate
    Arnold, Dirk
    Koller, Michael
    Schlitt, Hans J.
    Piso, Pompiliu
    [J]. CLINICAL COLORECTAL CANCER, 2018, 17 (04) : 285 - 296
  • [8] Gastric cancer
    Hartgrink, Henk H.
    Jansen, Edwin P. M.
    van Grieken, Nicole C. T.
    van de Velde, Cornelis J. H.
    [J]. LANCET, 2009, 374 (9688) : 477 - 490
  • [9] Current status and future prospects of clinical trials on CRS plus HIPEC for gastric cancer peritoneal metastases
    Ji, Zhong-He
    Peng, Kai-Wen
    Yu, Yang
    Li, Xin-Bao
    Yonemura, Yutaka
    Liu, Yang
    Sugarbaker, Paul H.
    Li, Yan
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2017, 33 (05) : 562 - 570
  • [10] Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion
    Kang, Lung-Yun
    Mok, King-Tong
    Liu, Shiuh-Inn
    Tsai, Cheng-Chong
    Wang, Being-Whey
    Chen, I-Shu
    Chen, Yu-Chia
    Chang, Bo-Min
    Chou, Nan-Hua
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (08) : 425 - 431
12